Wednesday, 16 October 2019

Most Popular
Pharma News
BioTech News
MedTech News
BioServices News
Video Gallery

Inside Magazine

Improved regulatory support push Clinical Research in Asia

 The prevalence of infectious and tropical diseases is creating an unmet clinical needs in emerging countries. Owing to these, a large number of the population participate in clinical trials to access high-quality healthcare free of cost. India and China have the highest prevalence rates for metabolic disorders, due to the increasing population, combined with the prevalence of insulin resistance, hyperlipidemia, and obesity. Besides the Asian region has the potential for large patient recruitment, cost reduction, the improved regulatory environment making it a favourable destination for clinical trials.

Sign up here to access BioSpectrum Asia flip book.



Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls